We are live on ! Find out more
AGN

Allergan Inc
AGN

Delisted

AGN was delisted on the 16th of March, 2015.

16 hedge funds and large institutions have $103M invested in Allergan Inc in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

645% more capital invested

Capital invested by funds: $13.9M → $103M (+$89.4M)

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

23% more funds holding

Funds holding: 1316 (+3)

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

AGN Hedge Fund Activity: Q3 2016 in Review

16 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q3 2016, worth a combined $103M — up 645% from $13.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AGN positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Frontier Investment Management, adding an estimated $18.2M. The largest seller was Chartist Inc, cutting an estimated $34.1K.

  • 16 institutional investors held Allergan Inc (AGN) as of Q3 2016, up from 13 in Q2 2016.
  • Funds reported $103M of Allergan Inc stock for Q3 2016, up 645% quarter-over-quarter.
  • 3 funds opened new Allergan Inc positions in Q3 2016 and 0 closed out, a net change of +3 holders.
  • The largest Allergan Inc buyer in Q3 2016 was Frontier Investment Management, an estimated $18.2M added.
  • The largest Allergan Inc seller in Q3 2016 was Chartist Inc, an estimated $34.1K sold.

Based on aggregated 13F filings for Q3 2016.